tiprankstipranks

Peter Kim Insider Profile

4 Followers
Peter Kim, Exe V-P & Pres, MRL at Merck & Company, holds 62.94K shares in Entrada Therapeutics Inc (Ticker: TRDA), holds 190.96K shares in Merck & Company (Ticker: MRK). Most recently, Peter Kim Bought ― shares of Entrada Therapeutics Inc on Apr 10, 2024 for an estimated value of 35.28K.
tipranks
Peter Kim

Peter Kim
Merck & Company (MRK)
Exe V-P & Pres, MRL

Ranked #52,090 out of 98,743 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-1.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$25M
96.71%
3.29%
A breakdown of Peter Kim's holdings

Insider Roles

Merck & Company
(MRK)
Exe V-P & Pres, MRL
Entrada Therapeutics Inc
(TRDA)
Director
Roles that Peter Kim holds in companies

Most Profitable Insider Trade

Stock:
Entrada Therapeutics Inc
(TRDA)
Rating:Informative Buy
Date:Apr 10, 2024 - Today
Return:+5.10%
The most profitable trade made by Peter Kim

Peter Kim's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Merck & Company
Feb 27, 2013
Exe V-P & Pres, MRL
Uninformative Buy
803.76K
$24.35M
Entrada Therapeutics Inc
Apr 10, 2024
Director
Informative Buy
35.28K
$828.24K
List of latest transactions for each holding click on a transaction to see Peter Kim's performance on stock

Peter Kim insider profile FAQ

What is the percentage of profitable transactions made by Peter Kim?
The percentage of profitable transactions made by Peter Kim is 25%.
    What is the average return per transaction made by Peter Kim?
    The average return per transaction made by Peter Kim is -1.50%.
      What stocks does Peter Kim hold?
      Peter Kim holds: MRK, TRDA stocks.
        What was Peter Kim’s latest transaction?
        Peter Kim latest transaction was an Informative Buy of $35.28K.
          What was Peter Kim's most profitable transaction?
          Peter Kim’s most profitable transaction was an Informative Buy of TRDA stock on April 10, 2024. The return on the trade was 5.10%.
            What is Peter Kim's role in Merck & Company?
            Peter Kim's role in Merck & Company is Exe V-P & Pres, MRL.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.